⌘K
Loading ticker…
Merck & Co., Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Merck & Co., Inc. (MRK) has a 3-month relative strength percentile of 55 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 59. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.6%, relative volume 1.49×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
55 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
MRK is in a stage 2 uptrend, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 11.1% / 21.0%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
MRK is held by 20 ETFs as of Mar 2026. Top owner: VTI at 0.47% weight, $9.4B notional. Top 3 carry $20.9B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.47% | $9.4B |
| VOOVanguard S&P 500 ETF | 0.53% | $7.6B |
| IVViShares Core S&P 500 ETF | 0.53% | $3.8B |
| SPYState Street SPDR S&P 500 ETF | 0.53% | $3.5B |
| VTVVanguard Value ETF | 1.22% | $2.8B |
| XLVState Street Health Care Select Sector SPDR ETF | 5.63% | $2.2B |
| IWDiShares Russell 1000 Value ETF | 0.98% | $687M |
| SPYMState Street SPDR Portfolio S&P 500 ETF | 0.53% | $628M |
| IVEiShares S&P 500 Value ETF | 1.11% | $515M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.47% | $375M |
Showing 10 of 20 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MRK Jan avg: 2.92% median: 2.05% win: 50% σ: 6.20% n: 4 2022-04-12 → 2026-05-29 | MRK Feb avg: 2.46% median: 2.09% win: 50% σ: 8.17% n: 4 2022-04-12 → 2026-05-29 | MRK Mar avg: -0.41% median: -1.28% win: 50% σ: 3.11% n: 4 2022-04-12 → 2026-05-29 | MRK Apr avg: -1.09% median: -2.07% win: 40% σ: 6.85% n: 5 2022-04-12 → 2026-05-29 | MRK May avg: -0.91% median: -2.85% win: 40% σ: 7.25% n: 5 2022-04-12 → 2026-05-29 | MRK Jun avg: 1.30% median: 1.04% win: 50% σ: 2.91% n: 4 2022-04-12 → 2026-05-29 (current) | MRK Jul avg: -4.88% median: -4.79% win: 0% σ: 3.75% n: 4 2022-04-12 → 2026-05-29 | MRK Aug avg: 2.53% median: 3.44% win: 75% σ: 5.17% n: 4 2022-04-12 → 2026-05-29 | MRK Sep avg: -2.25% median: -2.18% win: 25% σ: 3.07% n: 4 2022-04-12 → 2026-05-29 | MRK Oct avg: 2.45% median: 1.10% win: 50% σ: 11.35% n: 4 2022-04-12 → 2026-05-29 | MRK Nov avg: 7.46% median: 4.30% win: 50% σ: 10.58% n: 4 2022-04-12 → 2026-05-29 | MRK Dec avg: 1.35% median: 0.58% win: 75% σ: 3.59% n: 4 2022-04-12 → 2026-05-29 |